KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 19 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,154,000 | +160.1% | 5,000,000 | +150.0% | 0.15% | +163.2% |
| Q4 2021 | $1,597,000 | +6.9% | 2,000,000 | 0.0% | 0.06% | -10.9% |
| Q3 2021 | $1,494,000 | -25.0% | 2,000,000 | 0.0% | 0.06% | -22.0% |
| Q2 2021 | $1,991,000 | -47.3% | 2,000,000 | -33.3% | 0.08% | -43.4% |
| Q4 2020 | $3,781,000 | +4.9% | 3,000,000 | 0.0% | 0.14% | -14.7% |
| Q3 2020 | $3,603,000 | +28.2% | 3,000,000 | +50.0% | 0.17% | +6.9% |
| Q2 2020 | $2,811,000 | -35.2% | 2,000,000 | -33.3% | 0.16% | -53.5% |
| Q1 2020 | $4,337,000 | +0.4% | 3,000,000 | 0.0% | 0.34% | +43.1% |
| Q4 2019 | $4,318,000 | – | 3,000,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 8,000,000 | $5,215,000 | 9.09% |
| BRAIDWELL LP | 65,976,000 | $40,943,996 | 1.29% |
| Context Capital Management, LLC | 21,494 | $13,329 | 1.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,500,000 | $20,663,750 | 0.86% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $15,264,731 | 0.24% |
| DeepCurrents Investment Group LLC | 4,250,000 | $2,700,994 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $4,654,419 | 0.02% |
| Verition Fund Management LLC | 1,359 | $843,381 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 6,500,000 | $4,033 | 0.01% |
| BLB&B Advisors, LLC | 75,000 | $45,794 | 0.00% |